img

Global Autoimmune Disease Diagnostics Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Autoimmune Disease Diagnostics Market Research Report 2024

The diagnosis of autoimmune diseases depends on the identification of disease-associated clinical symptoms and is associated with the detection of autoantibodies. Clinicians conventionally classify autoimmune diseases as either systemic or organ-specific.
According to Mr Accuracy reports’s new survey, global Autoimmune Disease Diagnostics market is projected to reach US$ 6801.2 million in 2034, increasing from US$ 4906.4 million in 2022, with the CAGR of 4.7% during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Autoimmune Disease Diagnostics market research.
In terms of geography, the Americas led the global autoimmune disease diagnostics market and will continue to dominate the market in the coming years. The growing incidence of autoimmune disorders such as RA, SLE, and IBD will aid in the growth of this market. Also, the extensive R&D activities has allowed the launch of novel diagnostic products, which are expected to drive the adoption rates for autoimmune diagnostics in the Americas.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Autoimmune Disease Diagnostics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Abbott Laboratories
Beckman Coulter
Bio-Rad Laboratories
EUROIMMUN
Inova Diagnostics
Roche Diagnostics
Siemens Healthcare
DiaSorin
ERBA Diagnostics
Euro Diagnostica
Autoimmune Technologies
Avant Diagnostics
Exagen Diagnostics
Gold Standard Diagnostics
HOB Diagnostics
HUMAN Diagnostics
Immco Diagnostics
ImmunArray
Myriad Genetics
Omega Diagnostics
ORGENTEC Diagnostika
Phadia
Protagen
Segment by Type
Analyzers
Assay Kits

Segment by Application


Hospitals
Research Laboratories
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Autoimmune Disease Diagnostics report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autoimmune Disease Diagnostics Market Size Growth Rate by Type: 2024 VS 2022 VS 2034
1.2.2 Analyzers
1.2.3 Assay Kits
1.3 Market by Application
1.3.1 Global Autoimmune Disease Diagnostics Market Growth by Application: 2024 VS 2022 VS 2034
1.3.2 Hospitals
1.3.3 Research Laboratories
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Autoimmune Disease Diagnostics Market Perspective (2024-2034)
2.2 Autoimmune Disease Diagnostics Growth Trends by Region
2.2.1 Global Autoimmune Disease Diagnostics Market Size by Region: 2024 VS 2022 VS 2034
2.2.2 Autoimmune Disease Diagnostics Historic Market Size by Region (2024-2024)
2.2.3 Autoimmune Disease Diagnostics Forecasted Market Size by Region (2024-2034)
2.3 Autoimmune Disease Diagnostics Market Dynamics
2.3.1 Autoimmune Disease Diagnostics Industry Trends
2.3.2 Autoimmune Disease Diagnostics Market Drivers
2.3.3 Autoimmune Disease Diagnostics Market Challenges
2.3.4 Autoimmune Disease Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Autoimmune Disease Diagnostics Players by Revenue
3.1.1 Global Top Autoimmune Disease Diagnostics Players by Revenue (2024-2024)
3.1.2 Global Autoimmune Disease Diagnostics Revenue Market Share by Players (2024-2024)
3.2 Global Autoimmune Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Autoimmune Disease Diagnostics Revenue
3.4 Global Autoimmune Disease Diagnostics Market Concentration Ratio
3.4.1 Global Autoimmune Disease Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autoimmune Disease Diagnostics Revenue in 2022
3.5 Autoimmune Disease Diagnostics Key Players Head office and Area Served
3.6 Key Players Autoimmune Disease Diagnostics Product Solution and Service
3.7 Date of Enter into Autoimmune Disease Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Autoimmune Disease Diagnostics Breakdown Data by Type
4.1 Global Autoimmune Disease Diagnostics Historic Market Size by Type (2024-2024)
4.2 Global Autoimmune Disease Diagnostics Forecasted Market Size by Type (2024-2034)
5 Autoimmune Disease Diagnostics Breakdown Data by Application
5.1 Global Autoimmune Disease Diagnostics Historic Market Size by Application (2024-2024)
5.2 Global Autoimmune Disease Diagnostics Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Autoimmune Disease Diagnostics Market Size (2024-2034)
6.2 North America Autoimmune Disease Diagnostics Market Growth Rate by Country: 2024 VS 2022 VS 2034
6.3 North America Autoimmune Disease Diagnostics Market Size by Country (2024-2024)
6.4 North America Autoimmune Disease Diagnostics Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Autoimmune Disease Diagnostics Market Size (2024-2034)
7.2 Europe Autoimmune Disease Diagnostics Market Growth Rate by Country: 2024 VS 2022 VS 2034
7.3 Europe Autoimmune Disease Diagnostics Market Size by Country (2024-2024)
7.4 Europe Autoimmune Disease Diagnostics Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Autoimmune Disease Diagnostics Market Size (2024-2034)
8.2 Asia-Pacific Autoimmune Disease Diagnostics Market Growth Rate by Region: 2024 VS 2022 VS 2034
8.3 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Region (2024-2024)
8.4 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Autoimmune Disease Diagnostics Market Size (2024-2034)
9.2 Latin America Autoimmune Disease Diagnostics Market Growth Rate by Country: 2024 VS 2022 VS 2034
9.3 Latin America Autoimmune Disease Diagnostics Market Size by Country (2024-2024)
9.4 Latin America Autoimmune Disease Diagnostics Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Autoimmune Disease Diagnostics Market Size (2024-2034)
10.2 Middle East & Africa Autoimmune Disease Diagnostics Market Growth Rate by Country: 2024 VS 2022 VS 2034
10.3 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Country (2024-2024)
10.4 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Autoimmune Disease Diagnostics Introduction
11.1.4 Abbott Laboratories Revenue in Autoimmune Disease Diagnostics Business (2024-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Beckman Coulter
11.2.1 Beckman Coulter Company Detail
11.2.2 Beckman Coulter Business Overview
11.2.3 Beckman Coulter Autoimmune Disease Diagnostics Introduction
11.2.4 Beckman Coulter Revenue in Autoimmune Disease Diagnostics Business (2024-2024)
11.2.5 Beckman Coulter Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Detail
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Autoimmune Disease Diagnostics Introduction
11.3.4 Bio-Rad Laboratories Revenue in Autoimmune Disease Diagnostics Business (2024-2024)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 EUROIMMUN
11.4.1 EUROIMMUN Company Detail
11.4.2 EUROIMMUN Business Overview
11.4.3 EUROIMMUN Autoimmune Disease Diagnostics Introduction
11.4.4 EUROIMMUN Revenue in Autoimmune Disease Diagnostics Business (2024-2024)
11.4.5 EUROIMMUN Recent Development
11.5 Inova Diagnostics
11.5.1 Inova Diagnostics Company Detail
11.5.2 Inova Diagnostics Business Overview
11.5.3 Inova Diagnostics Autoimmune Disease Diagnostics Introduction
11.5.4 Inova Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2024-2024)
11.5.5 Inova Diagnostics Recent Development
11.6 Roche Diagnostics
11.6.1 Roche Diagnostics Company Detail
11.6.2 Roche Diagnostics Business Overview
11.6.3 Roche Diagnostics Autoimmune Disease Diagnostics Introduction
11.6.4 Roche Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2024-2024)
11.6.5 Roche Diagnostics Recent Development
11.7 Siemens Healthcare
11.7.1 Siemens Healthcare Company Detail
11.7.2 Siemens Healthcare Business Overview
11.7.3 Siemens Healthcare Autoimmune Disease Diagnostics Introduction
11.7.4 Siemens Healthcare Revenue in Autoimmune Disease Diagnostics Business (2024-2024)
11.7.5 Siemens Healthcare Recent Development
11.8 DiaSorin
11.8.1 DiaSorin Company Detail
11.8.2 DiaSorin Business Overview
11.8.3 DiaSorin Autoimmune Disease Diagnostics Introduction
11.8.4 DiaSorin Revenue in Autoimmune Disease Diagnostics Business (2024-2024)
11.8.5 DiaSorin Recent Development
11.9 ERBA Diagnostics
11.9.1 ERBA Diagnostics Company Detail
11.9.2 ERBA Diagnostics Business Overview
11.9.3 ERBA Diagnostics Autoimmune Disease Diagnostics Introduction
11.9.4 ERBA Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2024-2024)
11.9.5 ERBA Diagnostics Recent Development
11.10 Euro Diagnostica
11.10.1 Euro Diagnostica Company Detail
11.10.2 Euro Diagnostica Business Overview
11.10.3 Euro Diagnostica Autoimmune Disease Diagnostics Introduction
11.10.4 Euro Diagnostica Revenue in Autoimmune Disease Diagnostics Business (2024-2024)
11.10.5 Euro Diagnostica Recent Development
11.11 Autoimmune Technologies
11.11.1 Autoimmune Technologies Company Detail
11.11.2 Autoimmune Technologies Business Overview
11.11.3 Autoimmune Technologies Autoimmune Disease Diagnostics Introduction
11.11.4 Autoimmune Technologies Revenue in Autoimmune Disease Diagnostics Business (2024-2024)
11.11.5 Autoimmune Technologies Recent Development
11.12 Avant Diagnostics
11.12.1 Avant Diagnostics Company Detail
11.12.2 Avant Diagnostics Business Overview
11.12.3 Avant Diagnostics Autoimmune Disease Diagnostics Introduction
11.12.4 Avant Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2024-2024)
11.12.5 Avant Diagnostics Recent Development
11.13 Exagen Diagnostics
11.13.1 Exagen Diagnostics Company Detail
11.13.2 Exagen Diagnostics Business Overview
11.13.3 Exagen Diagnostics Autoimmune Disease Diagnostics Introduction
11.13.4 Exagen Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2024-2024)
11.13.5 Exagen Diagnostics Recent Development
11.14 Gold Standard Diagnostics
11.14.1 Gold Standard Diagnostics Company Detail
11.14.2 Gold Standard Diagnostics Business Overview
11.14.3 Gold Standard Diagnostics Autoimmune Disease Diagnostics Introduction
11.14.4 Gold Standard Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2024-2024)
11.14.5 Gold Standard Diagnostics Recent Development
11.15 HOB Diagnostics
11.15.1 HOB Diagnostics Company Detail
11.15.2 HOB Diagnostics Business Overview
11.15.3 HOB Diagnostics Autoimmune Disease Diagnostics Introduction
11.15.4 HOB Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2024-2024)
11.15.5 HOB Diagnostics Recent Development
11.16 HUMAN Diagnostics
11.16.1 HUMAN Diagnostics Company Detail
11.16.2 HUMAN Diagnostics Business Overview
11.16.3 HUMAN Diagnostics Autoimmune Disease Diagnostics Introduction
11.16.4 HUMAN Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2024-2024)
11.16.5 HUMAN Diagnostics Recent Development
11.17 Immco Diagnostics
11.17.1 Immco Diagnostics Company Detail
11.17.2 Immco Diagnostics Business Overview
11.17.3 Immco Diagnostics Autoimmune Disease Diagnostics Introduction
11.17.4 Immco Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2024-2024)
11.17.5 Immco Diagnostics Recent Development
11.18 ImmunArray
11.18.1 ImmunArray Company Detail
11.18.2 ImmunArray Business Overview
11.18.3 ImmunArray Autoimmune Disease Diagnostics Introduction
11.18.4 ImmunArray Revenue in Autoimmune Disease Diagnostics Business (2024-2024)
11.18.5 ImmunArray Recent Development
11.19 Myriad Genetics
11.19.1 Myriad Genetics Company Detail
11.19.2 Myriad Genetics Business Overview
11.19.3 Myriad Genetics Autoimmune Disease Diagnostics Introduction
11.19.4 Myriad Genetics Revenue in Autoimmune Disease Diagnostics Business (2024-2024)
11.19.5 Myriad Genetics Recent Development
11.20 Omega Diagnostics
11.20.1 Omega Diagnostics Company Detail
11.20.2 Omega Diagnostics Business Overview
11.20.3 Omega Diagnostics Autoimmune Disease Diagnostics Introduction
11.20.4 Omega Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2024-2024)
11.20.5 Omega Diagnostics Recent Development
11.21 ORGENTEC Diagnostika
11.21.1 ORGENTEC Diagnostika Company Detail
11.21.2 ORGENTEC Diagnostika Business Overview
11.21.3 ORGENTEC Diagnostika Autoimmune Disease Diagnostics Introduction
11.21.4 ORGENTEC Diagnostika Revenue in Autoimmune Disease Diagnostics Business (2024-2024)
11.21.5 ORGENTEC Diagnostika Recent Development
11.22 Phadia
11.22.1 Phadia Company Detail
11.22.2 Phadia Business Overview
11.22.3 Phadia Autoimmune Disease Diagnostics Introduction
11.22.4 Phadia Revenue in Autoimmune Disease Diagnostics Business (2024-2024)
11.22.5 Phadia Recent Development
11.23 Protagen
11.23.1 Protagen Company Detail
11.23.2 Protagen Business Overview
11.23.3 Protagen Autoimmune Disease Diagnostics Introduction
11.23.4 Protagen Revenue in Autoimmune Disease Diagnostics Business (2024-2024)
11.23.5 Protagen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Autoimmune Disease Diagnostics Market Size Growth Rate by Type (US$ Million): 2024 VS 2022 VS 2034
Table 2. Key Players of Analyzers
Table 3. Key Players of Assay Kits
Table 4. Global Autoimmune Disease Diagnostics Market Size Growth by Application (US$ Million): 2024 VS 2022 VS 2034
Table 5. Global Autoimmune Disease Diagnostics Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 6. Global Autoimmune Disease Diagnostics Market Size by Region (2024-2024) & (US$ Million)
Table 7. Global Autoimmune Disease Diagnostics Market Share by Region (2024-2024)
Table 8. Global Autoimmune Disease Diagnostics Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 9. Global Autoimmune Disease Diagnostics Market Share by Region (2024-2034)
Table 10. Autoimmune Disease Diagnostics Market Trends
Table 11. Autoimmune Disease Diagnostics Market Drivers
Table 12. Autoimmune Disease Diagnostics Market Challenges
Table 13. Autoimmune Disease Diagnostics Market Restraints
Table 14. Global Autoimmune Disease Diagnostics Revenue by Players (2024-2024) & (US$ Million)
Table 15. Global Autoimmune Disease Diagnostics Market Share by Players (2024-2024)
Table 16. Global Top Autoimmune Disease Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Disease Diagnostics as of 2022)
Table 17. Ranking of Global Top Autoimmune Disease Diagnostics Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Autoimmune Disease Diagnostics Revenue (CR5 and HHI) & (2024-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Autoimmune Disease Diagnostics Product Solution and Service
Table 21. Date of Enter into Autoimmune Disease Diagnostics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Autoimmune Disease Diagnostics Market Size by Type (2024-2024) & (US$ Million)
Table 24. Global Autoimmune Disease Diagnostics Revenue Market Share by Type (2024-2024)
Table 25. Global Autoimmune Disease Diagnostics Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 26. Global Autoimmune Disease Diagnostics Revenue Market Share by Type (2024-2034)
Table 27. Global Autoimmune Disease Diagnostics Market Size by Application (2024-2024) & (US$ Million)
Table 28. Global Autoimmune Disease Diagnostics Revenue Market Share by Application (2024-2024)
Table 29. Global Autoimmune Disease Diagnostics Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 30. Global Autoimmune Disease Diagnostics Revenue Market Share by Application (2024-2034)
Table 31. North America Autoimmune Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 32. North America Autoimmune Disease Diagnostics Market Size by Country (2024-2024) & (US$ Million)
Table 33. North America Autoimmune Disease Diagnostics Market Size by Country (2024-2034) & (US$ Million)
Table 34. Europe Autoimmune Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 35. Europe Autoimmune Disease Diagnostics Market Size by Country (2024-2024) & (US$ Million)
Table 36. Europe Autoimmune Disease Diagnostics Market Size by Country (2024-2034) & (US$ Million)
Table 37. Asia-Pacific Autoimmune Disease Diagnostics Market Size Growth Rate by Region (US$ Million): 2024 VS 2022 VS 2034
Table 38. Asia-Pacific Autoimmune Disease Diagnostics Market Size by Region (2024-2024) & (US$ Million)
Table 39. Asia-Pacific Autoimmune Disease Diagnostics Market Size by Region (2024-2034) & (US$ Million)
Table 40. Latin America Autoimmune Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 41. Latin America Autoimmune Disease Diagnostics Market Size by Country (2024-2024) & (US$ Million)
Table 42. Latin America Autoimmune Disease Diagnostics Market Size by Country (2024-2034) & (US$ Million)
Table 43. Middle East & Africa Autoimmune Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 44. Middle East & Africa Autoimmune Disease Diagnostics Market Size by Country (2024-2024) & (US$ Million)
Table 45. Middle East & Africa Autoimmune Disease Diagnostics Market Size by Country (2024-2034) & (US$ Million)
Table 46. Abbott Laboratories Company Detail
Table 47. Abbott Laboratories Business Overview
Table 48. Abbott Laboratories Autoimmune Disease Diagnostics Product
Table 49. Abbott Laboratories Revenue in Autoimmune Disease Diagnostics Business (2024-2024) & (US$ Million)
Table 50. Abbott Laboratories Recent Development
Table 51. Beckman Coulter Company Detail
Table 52. Beckman Coulter Business Overview
Table 53. Beckman Coulter Autoimmune Disease Diagnostics Product
Table 54. Beckman Coulter Revenue in Autoimmune Disease Diagnostics Business (2024-2024) & (US$ Million)
Table 55. Beckman Coulter Recent Development
Table 56. Bio-Rad Laboratories Company Detail
Table 57. Bio-Rad Laboratories Business Overview
Table 58. Bio-Rad Laboratories Autoimmune Disease Diagnostics Product
Table 59. Bio-Rad Laboratories Revenue in Autoimmune Disease Diagnostics Business (2024-2024) & (US$ Million)
Table 60. Bio-Rad Laboratories Recent Development
Table 61. EUROIMMUN Company Detail
Table 62. EUROIMMUN Business Overview
Table 63. EUROIMMUN Autoimmune Disease Diagnostics Product
Table 64. EUROIMMUN Revenue in Autoimmune Disease Diagnostics Business (2024-2024) & (US$ Million)
Table 65. EUROIMMUN Recent Development
Table 66. Inova Diagnostics Company Detail
Table 67. Inova Diagnostics Business Overview
Table 68. Inova Diagnostics Autoimmune Disease Diagnostics Product
Table 69. Inova Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2024-2024) & (US$ Million)
Table 70. Inova Diagnostics Recent Development
Table 71. Roche Diagnostics Company Detail
Table 72. Roche Diagnostics Business Overview
Table 73. Roche Diagnostics Autoimmune Disease Diagnostics Product
Table 74. Roche Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2024-2024) & (US$ Million)
Table 75. Roche Diagnostics Recent Development
Table 76. Siemens Healthcare Company Detail
Table 77. Siemens Healthcare Business Overview
Table 78. Siemens Healthcare Autoimmune Disease Diagnostics Product
Table 79. Siemens Healthcare Revenue in Autoimmune Disease Diagnostics Business (2024-2024) & (US$ Million)
Table 80. Siemens Healthcare Recent Development
Table 81. DiaSorin Company Detail
Table 82. DiaSorin Business Overview
Table 83. DiaSorin Autoimmune Disease Diagnostics Product
Table 84. DiaSorin Revenue in Autoimmune Disease Diagnostics Business (2024-2024) & (US$ Million)
Table 85. DiaSorin Recent Development
Table 86. ERBA Diagnostics Company Detail
Table 87. ERBA Diagnostics Business Overview
Table 88. ERBA Diagnostics Autoimmune Disease Diagnostics Product
Table 89. ERBA Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2024-2024) & (US$ Million)
Table 90. ERBA Diagnostics Recent Development
Table 91. Euro Diagnostica Company Detail
Table 92. Euro Diagnostica Business Overview
Table 93. Euro Diagnostica Autoimmune Disease Diagnostics Product
Table 94. Euro Diagnostica Revenue in Autoimmune Disease Diagnostics Business (2024-2024) & (US$ Million)
Table 95. Euro Diagnostica Recent Development
Table 96. Autoimmune Technologies Company Detail
Table 97. Autoimmune Technologies Business Overview
Table 98. Autoimmune Technologies Autoimmune Disease Diagnostics Product
Table 99. Autoimmune Technologies Revenue in Autoimmune Disease Diagnostics Business (2024-2024) & (US$ Million)
Table 100. Autoimmune Technologies Recent Development
Table 101. Avant Diagnostics Company Detail
Table 102. Avant Diagnostics Business Overview
Table 103. Avant Diagnostics Autoimmune Disease Diagnostics Product
Table 104. Avant Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2024-2024) & (US$ Million)
Table 105. Avant Diagnostics Recent Development
Table 106. Exagen Diagnostics Company Detail
Table 107. Exagen Diagnostics Business Overview
Table 108. Exagen Diagnostics Autoimmune Disease Diagnostics Product
Table 109. Exagen Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2024-2024) & (US$ Million)
Table 110. Exagen Diagnostics Recent Development
Table 111. Gold Standard Diagnostics Company Detail
Table 112. Gold Standard Diagnostics Business Overview
Table 113. Gold Standard Diagnostics Autoimmune Disease Diagnostics Product
Table 114. Gold Standard Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2024-2024) & (US$ Million)
Table 115. Gold Standard Diagnostics Recent Development
Table 116. HOB Diagnostics Company Detail
Table 117. HOB Diagnostics Business Overview
Table 118. HOB Diagnostics Autoimmune Disease Diagnostics Product
Table 119. HOB Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2024-2024) & (US$ Million)
Table 120. HOB Diagnostics Recent Development
Table 121. HUMAN Diagnostics Company Detail
Table 122. HUMAN Diagnostics Business Overview
Table 123. HUMAN Diagnostics Autoimmune Disease Diagnostics Product
Table 124. HUMAN Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2024-2024) & (US$ Million)
Table 125. HUMAN Diagnostics Recent Development
Table 126. Immco Diagnostics Company Detail
Table 127. Immco Diagnostics Business Overview
Table 128. Immco Diagnostics Autoimmune Disease Diagnostics Product
Table 129. Immco Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2024-2024) & (US$ Million)
Table 130. Immco Diagnostics Recent Development
Table 131. ImmunArray Company Detail
Table 132. ImmunArray Business Overview
Table 133. ImmunArray Autoimmune Disease Diagnostics Product
Table 134. ImmunArray Revenue in Autoimmune Disease Diagnostics Business (2024-2024) & (US$ Million)
Table 135. ImmunArray Recent Development
Table 136. Myriad Genetics Company Detail
Table 137. Myriad Genetics Business Overview
Table 138. Myriad Genetics Autoimmune Disease Diagnostics Product
Table 139. Myriad Genetics Revenue in Autoimmune Disease Diagnostics Business (2024-2024) & (US$ Million)
Table 140. Myriad Genetics Recent Development
Table 141. Omega Diagnostics Company Detail
Table 142. Omega Diagnostics Business Overview
Table 143. Omega Diagnostics Autoimmune Disease Diagnostics Product
Table 144. Omega Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2024-2024) & (US$ Million)
Table 145. Omega Diagnostics Recent Development
Table 146. ORGENTEC Diagnostika Company Detail
Table 147. ORGENTEC Diagnostika Business Overview
Table 148. ORGENTEC Diagnostika Autoimmune Disease Diagnostics Product
Table 149. ORGENTEC Diagnostika Revenue in Autoimmune Disease Diagnostics Business (2024-2024) & (US$ Million)
Table 150. ORGENTEC Diagnostika Recent Development
Table 151. Phadia Company Detail
Table 152. Phadia Business Overview
Table 153. Phadia Autoimmune Disease Diagnostics Product
Table 154. Phadia Revenue in Autoimmune Disease Diagnostics Business (2024-2024) & (US$ Million)
Table 155. Phadia Recent Development
Table 156. Protagen Company Detail
Table 157. Protagen Business Overview
Table 158. Protagen Autoimmune Disease Diagnostics Product
Table 159. Protagen Revenue in Autoimmune Disease Diagnostics Business (2024-2024) & (US$ Million)
Table 160. Protagen Recent Development
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Autoimmune Disease Diagnostics Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Autoimmune Disease Diagnostics Market Share by Type: 2022 VS 2034
Figure 3. Analyzers Features
Figure 4. Assay Kits Features
Figure 5. Global Autoimmune Disease Diagnostics Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 6. Global Autoimmune Disease Diagnostics Market Share by Application: 2022 VS 2034
Figure 7. Hospitals Case Studies
Figure 8. Research Laboratories Case Studies
Figure 9. Autoimmune Disease Diagnostics Report Years Considered
Figure 10. Global Autoimmune Disease Diagnostics Market Size (US$ Million), Year-over-Year: 2024-2034
Figure 11. Global Autoimmune Disease Diagnostics Market Size, (US$ Million), 2024 VS 2022 VS 2034
Figure 12. Global Autoimmune Disease Diagnostics Market Share by Region: 2022 VS 2034
Figure 13. Global Autoimmune Disease Diagnostics Market Share by Players in 2022
Figure 14. Global Top Autoimmune Disease Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Disease Diagnostics as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Autoimmune Disease Diagnostics Revenue in 2022
Figure 16. North America Autoimmune Disease Diagnostics Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 17. North America Autoimmune Disease Diagnostics Market Share by Country (2024-2034)
Figure 18. United States Autoimmune Disease Diagnostics Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 19. Canada Autoimmune Disease Diagnostics Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 20. Europe Autoimmune Disease Diagnostics Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 21. Europe Autoimmune Disease Diagnostics Market Share by Country (2024-2034)
Figure 22. Germany Autoimmune Disease Diagnostics Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 23. France Autoimmune Disease Diagnostics Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 24. U.K. Autoimmune Disease Diagnostics Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 25. Italy Autoimmune Disease Diagnostics Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 26. Russia Autoimmune Disease Diagnostics Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 27. Nordic Countries Autoimmune Disease Diagnostics Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 28. Asia-Pacific Autoimmune Disease Diagnostics Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 29. Asia-Pacific Autoimmune Disease Diagnostics Market Share by Region (2024-2034)
Figure 30. China Autoimmune Disease Diagnostics Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 31. Japan Autoimmune Disease Diagnostics Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 32. South Korea Autoimmune Disease Diagnostics Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 33. Southeast Asia Autoimmune Disease Diagnostics Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 34. India Autoimmune Disease Diagnostics Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 35. Australia Autoimmune Disease Diagnostics Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 36. Latin America Autoimmune Disease Diagnostics Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 37. Latin America Autoimmune Disease Diagnostics Market Share by Country (2024-2034)
Figure 38. Mexico Autoimmune Disease Diagnostics Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 39. Brazil Autoimmune Disease Diagnostics Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 40. Middle East & Africa Autoimmune Disease Diagnostics Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 41. Middle East & Africa Autoimmune Disease Diagnostics Market Share by Country (2024-2034)
Figure 42. Turkey Autoimmune Disease Diagnostics Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 43. Saudi Arabia Autoimmune Disease Diagnostics Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 44. Abbott Laboratories Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2024-2024)
Figure 45. Beckman Coulter Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2024-2024)
Figure 46. Bio-Rad Laboratories Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2024-2024)
Figure 47. EUROIMMUN Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2024-2024)
Figure 48. Inova Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2024-2024)
Figure 49. Roche Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2024-2024)
Figure 50. Siemens Healthcare Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2024-2024)
Figure 51. DiaSorin Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2024-2024)
Figure 52. ERBA Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2024-2024)
Figure 53. Euro Diagnostica Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2024-2024)
Figure 54. Autoimmune Technologies Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2024-2024)
Figure 55. Avant Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2024-2024)
Figure 56. Exagen Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2024-2024)
Figure 57. Gold Standard Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2024-2024)
Figure 58. HOB Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2024-2024)
Figure 59. HUMAN Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2024-2024)
Figure 60. Immco Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2024-2024)
Figure 61. ImmunArray Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2024-2024)
Figure 62. Myriad Genetics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2024-2024)
Figure 63. Omega Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2024-2024)
Figure 64. ORGENTEC Diagnostika Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2024-2024)
Figure 65. Phadia Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2024-2024)
Figure 66. Protagen Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2024-2024)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed